Fresh analysis suggests that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Published data in a major medical journal points out that while overweight people frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals using these treatments need to be cognizant of the risk of rapid weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain suggests a return to original mass within about a year and a half.
Weighing Treatments
The research, which reviewed dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with conventional dieting.
Researchers point out that individuals who shed pounds through diet and exercise generally see a less rapid creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Experts believe the mechanism of the jabs is key to understanding the heightened rebound.
The injections copy a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."
A Lifelong Condition?
Health authorities recommend the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians say that, due to the high risk of relapse, the therapy might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," comparing it to managing conditions like diabetes.
Patient Accounts
Individuals who have come off the medication describe a powerful return of appetite.
"It felt as if something activating and you become ravenous," described one woman.
The struggle is exacerbated if users have not established permanent lifestyle or habit changes during therapy.
Growing Interest
Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private healthcare rather than public health services.
Ultimately, researchers stress that while the jabs are potent agents for weight loss, they are not a standalone cure and long-term success likely depends on integrated lifestyle support.
